Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 17 Nov 2016 Results published in the Endo International Media Release.
- 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
- 26 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History